🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Congenital Hearing Loss

Analysis of Parental Support in Families Using the LENA After Early Cochlear Implantation NCT05917496n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: LENA tool: Language ENvironment Analysis, Return of the analysis of the data of LENA Effects of Bisphosphonates on OI-Related Hearing Loss NCT04152551Phase 41 site📍 New York Hospital for Special Surgery, New York · Tests: Risedronate Oral Tablet Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset NCT06475651n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Methylation analysis Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site📍 Columbia Foundation Fighting Blindness GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies Cochlear Implants in Young Children With SSD NCT05775367NA1 site📍 Durham University of North Carolina, Chapel Hill · Tests: Cochlear Implant Pitch Perception and Memory: Deficits and Training NCT03707691NA1 site📍 Bron Hospices Civils de Lyon · Tests: Listening tests. Pitch training protocol, visuo-spatial training protocol, EEG/MEG/MRI recordings. Long-Term Outcomes of Children With Congenital CMV in New York State NCT06226558n/a1 site📍 Stony Brook Stony Brook University Adaptive Optics Imaging of Outer Retinal Diseases NCT05355415n/a2 sites📍 Bethesda📍 Silver Spring Food and Drug Administration (FDA) · Tests: Adaptive optics imaging Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection NCT07635368n/a2 sites📍 Copenhagen📍 Copenhagen Copenhagen University Hospital, Rigshospitalet A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome NCT07710196Phase 31 site📍 Dallas Nacuity Pharmaceuticals, Inc. · Tests: Placebo, NPI-001 Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels NCT05241262Phase 11 site📍 New York Michio Hirano, MD · Tests: N-Acetylcysteine Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Natural History Study for Charcot Marie Tooth Disease NCT05902351n/a1 site📍 New York Hereditary Neuropathy Foundation Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome NCT06507007n/a1 site📍 Herning Gødstrup Hospital Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa NCT06591793Phase 1, Phase 23 sites📍 Naples📍 London📍 London AAVantgarde Bio Srl · Tests: AAVB-081 North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) NCT01694940n/a17 sites📍 San Diego📍 Stanford📍 Aurora Columbia University Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss NCT07024524NA1 site📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: Rehabilitation training A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations NCT05788536Phase 1, Phase 217 sites📍 Los Angeles📍 San Diego📍 Jacksonville Regeneron Pharmaceuticals · Tests: DB-OTO Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes NCT05402813n/a1 site📍 Paris Sensorion · Tests: Pure Tone Audiometry Assessment, Quality of Life Questionnaires Monogenic Diabetes Misdiagnosed as Type 1 NCT03988764n/a1 site📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: None AHT A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations NCT07288580Phase 1, Phase 21 site📍 Shanghai Shanghai Euhearing Therapeutics Co., Ltd · Tests: EHT102 Injection Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study NCT02841553n/a1 site📍 St Louis Washington University School of Medicine A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) NCT06789445Phase 1, Phase 25 sites📍 Los Angeles📍 Miami📍 Philadelphia BlueRock Therapeutics · Tests: OpCT-001, OpCT-001 Stem Cell Ophthalmology Treatment Study II NCT03011541NA4 sites📍 Westport📍 Coral Springs📍 Vienna MD Stem Cells · Tests: Arm 1 Alpha-Tectorin, Interleukin-10 and Thiol-Disulfide Homeostasis in Children With Congenital Hearing Loss NCT07860580n/a1 site📍 Sanliurfa Harran University · Tests: Blood sample collection Natural History Study of Usher Syndrome ( Light4Deaf ) NCT04665726n/a4 sites📍 Paris📍 Paris📍 Paris Centre Hospitalier National d'Ophtalmologie des Quinze-Ving… Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance NCT07548944n/a1 site📍 Frankfurt am Main Okuvision GmbH · Tests: Transcorneal Electrical Stimulation using the OkuStim System Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta NCT05419960n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Vestibular Assessment, Petrous bone Computed Tomography (CT), Magnetic Resonance Imaging (MRI) KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases NCT06451757Phase 310 sites📍 Boston📍 Cleveland📍 Houston Khondrion BV · Tests: Sonlicromanol, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy